Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

73-40-5

Guanine USP

73-40-5
119018-29-0

Glimepiride Related Compound B

119018-29-0
NA

Gentamicin sulfate salt hydrate

NA
27750-13-6

(+)-Garcinia acid

27750-13-6
446-72-0

Genistein

446-72-0
184475-35-2

Gefitinib

184475-35-2
21187-98-4

Gliclazide

21187-98-4
93479-97-1

Glimepiride

93479-97-1
29094-61-9

Glipizide

29094-61-9
10238-21-8

Glibenclamide

10238-21-8
468-44-0

Gibberellin A4

468-44-0
510-75-8

Gibberellin A7

510-75-8
1405-86-3

Glycyrrhizin

1405-86-3
210353-53-0

Gemifloxacin Mesilate

210353-53-0
60282-87-3

Gestodene

60282-87-3
53956-04-0

Monoammonium Glycyrrhizinate Hydrate

53956-04-0
40246-10-4

Glycitin

40246-10-4
529-59-9

Genistin

529-59-9
67950-95-2

Gabapentin Related Compound E

67950-95-2
119018-30-3

Glimepiride Impurity C

119018-30-3